NCT07104448

Brief Summary

This is a prospective, randomized controlled trial to evaluate whether a comprehensive, standardized perioperative care protocol (SPCP) improves functional recovery, radiographic outcomes, and quality of life compared to conventional care in patients undergoing transforaminal lumbar interbody fusion (TLIF) for degenerative lumbar spondylolisthesis. The study aims to demonstrate that a protocol-driven approach can lead to better patient outcomes and increased healthcare efficiency.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
382

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2018

Completed
5.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2023

Completed
1.9 years until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2025

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

July 29, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 5, 2025

Completed
Last Updated

August 5, 2025

Status Verified

July 1, 2025

Enrollment Period

5.4 years

First QC Date

July 29, 2025

Last Update Submit

July 29, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in Oswestry Disability Index (ODI) Score

    The change in the ODI score from baseline to 2 years post-surgery. The ODI (version 2.1a) is a patient-reported outcome measure that assesses disability due to low back pain. Scores range from 0 to 100, with lower scores indicating less disability.

    Baseline, 2 years

Secondary Outcomes (8)

  • Change in Japanese Orthopaedic Association (JOA) Score

    Baseline, 3 months, 6 months, 1 year, 2 years

  • Change in Visual Analog Scale (VAS) for Back and Leg Pain

    Baseline, 3 months, 6 months, 1 year, 2 years

  • Change in Short Form-36 (SF-36) Quality of Life Scores

    Baseline, 3 months, 6 months, 1 year, 2 years

  • Radiographic Fusion Rate

    1 year, 2 years

  • Change in Segmental Lordosis

    Baseline, 1 year, 2 years

  • +3 more secondary outcomes

Study Arms (2)

Experimental: Standardized Perioperative Care Protocol (SPCP) Group

EXPERIMENTAL

Patients randomized to this group received a multi-modal, standardized protocol that included: comprehensive preoperative education and optimization; standardized intraoperative anesthesia and surgical techniques; and a structured postoperative rehabilitation program featuring multimodal analgesia and goal-directed early mobilization.

Behavioral: Standardized Perioperative Care Protocol

Active Comparator: Conventional Care Group

ACTIVE COMPARATOR

Patients randomized to this group received standard institutional care, which was not protocolized. This typically involved surgeon-preference-based perioperative management, variable timing for mobilization and catheter removal, and discharge based on the attending surgeon's general assessment.

Other: Conventional care

Interventions

A multi-component protocol involving preoperative patient education, nutritional screening, standardized anesthesia, goal-directed fluid therapy, multimodal opioid-sparing analgesia, and a structured physiotherapy-led mobilization schedule starting on postoperative day 1.

Experimental: Standardized Perioperative Care Protocol (SPCP) Group

Standard, non-protocolized institutional perioperative care, with management decisions based on the discretion of the attending surgeon and care team.

Active Comparator: Conventional Care Group

Eligibility Criteria

Age40 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Symptomatic, single-level (L3-L4, L4-L5, or L5-S1) degenerative spondylolisthesis (Meyerding Grade I or II).
  • Failure of at least 6 months of conservative therapy.
  • Age between 40 and 75 years.
  • Suitable for and scheduled to undergo transforaminal lumbar interbody fusion (TLIF) surgery.
  • Provided written informed consent.

You may not qualify if:

  • High-grade spondylolisthesis (Grade \> II).
  • History of previous lumbar surgery.
  • Presence of active spinal infection, tumor, or trauma.
  • Severe osteoporosis (T-score \< -3.0).
  • Significant medical comorbidities precluding major surgery (ASA physical status \> III).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Third Hospital of Hebei Medical University

Shijiazhuang, Hebei, 050000, China

Location

Related Publications (1)

  • Zhao Y, Wu J, Zhang Z, Wang Y, Li B. Impact of a standardized perioperative care protocol on functional and radiographic outcomes following transforaminal lumbar interbody fusion for degenerative spondylolisthesis: a 2-year randomized controlled trial. Front Surg. 2025 Dec 18;12:1679851. doi: 10.3389/fsurg.2025.1679851. eCollection 2025.

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

July 29, 2025

First Posted

August 5, 2025

Study Start

January 1, 2018

Primary Completion

June 1, 2023

Study Completion

May 1, 2025

Last Updated

August 5, 2025

Record last verified: 2025-07

Locations